UPDATE: KeyBanc Capital Markets Downgrades Xylem on Balance Risk-Reward
October 30, 2013 at 10:46 AM EDT
In a report published Wednesday, KeyBanc Capital Markets analyst Matt J. Summerville downgraded the rating on Xylem (NYSE: XYL ) from Buy to Hold, and named a $29.00 price target. In the report, KeyBanc Capital Markets noted, “We are reducing our rating on shares of Xylem, Inc. from BUY to
